Last year, FDAacting through the Office of Prescription Drug Promotion (OPDP) within the Center for Drug Evaluation and Research (CDER)issued a high volume of untitled and warning letters as part of a broader push against directtoconsumer (DTC) drug advertising, including 58 letters addressing claims about compounded GLP1s (e.g., semaglutide and tirzepatide) and other compounded products (e.g., sildenafil and tadalafil).[2] By mid2026, activity appeared to taper offraising the question whether FDA had shifted priorities, for example due to personnel changes, or simply paused the effort
While the drug is highly effective, some people decide to stop using it once they reach their target weight or if advised by their GP due to side effects or cost
Regular follow-up appointments will help monitor your progress, manage side effects, and adjust your treatment plan as needed
You might wonder why Semaglutide isnt available as a tablet
The outcome determines the rebate-adjusted price that GKV pays